Skip to main content
Clinical Trials/JPRN-UMIN000036418
JPRN-UMIN000036418
Completed
未知

Hemolysis of patients with end stage renal disease evaluated by erythrocyte creatine - Hemolysis of end stage renal disease

Kansai Medical University Medical Center0 sites69 target enrollmentApril 5, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
End stage renal disease
Sponsor
Kansai Medical University Medical Center
Enrollment
69
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 5, 2019
End Date
April 4, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with malignant tumor Patients with auto immune hemolytic anemia Patients who received transfusion within 3 months Patients with myelodysplastic syndromes

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Does Evening Primrose Oil Improve Pruritis (Itching) in a Dialysis Population?Pruritis in End Stage Renal FailureFree Fatty Acid Intake and levels in End Stage Renal FailureRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - Other metabolic disorders
ACTRN12614000677606Department of Renal Medicine, WOLLONGONG hOSPITA90
Not yet recruiting
Phase 2
A study to gain indepth understanding of Quality of Life of patients undergoing Hemodialysis and assess the effect of Family Empowerment program (Hemodialysis guide and Counseling) on Quality of Life, Adherence, Clinical Outcome and Care giver BurdeHealth Condition 1: N186- End stage renal disease
CTRI/2022/04/041933PARAMESWARI M
Unknown
Not Applicable
A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic FistulaeEnd Stage Renal Failure
NCT01704313Emma Aitken70
Completed
Not Applicable
Intensive versus Conventional Renal Support in Acute Renal FailureAcute Renal FailureRenal and Urogenital - Kidney disease
ACTRN12610000044022S Department of Veterans Affairs Cooperative Studies Program1,164
Active, not recruiting
Phase 1
Chronic anticoagulation in end-stage renal disease patients: pharmacocinetics and pharmacodynamic of a reduced dose regimen of rivaroxaban (CARD-AXA)Chronic hemodialysisMedDRA version: 21.1Level: LLTClassification code: 10066622Term: Chronic hemodialysis Class: 10042613Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
CTIS2023-505733-28-00Centre Hospitalier Regional Universitaire De Tours10